# Lundbeck

> Danish pharmaceutical company

**Wikidata**: [Q902171](https://www.wikidata.org/wiki/Q902171)  
**Wikipedia**: [English](https://en.wikipedia.org/wiki/Lundbeck)  
**Source**: https://4ort.xyz/entity/lundbeck

## Summary
Lundbeck is a Danish pharmaceutical company founded in 1915, specializing in the development, production, and marketing of drugs and pharmaceuticals. It is a publicly traded company listed on the Nasdaq Copenhagen stock exchange and is known for its contributions to the pharmaceutical industry, including notable products like citalopram and memantine.

## Key Facts
- Founded in 1915.
- Headquartered in Valby, Copenhagen, Denmark.
- Publicly traded company with shares listed on Nasdaq Copenhagen A/S.
- CEO: Kåre Schultz.
- Revenue: €22 billion (2023).
- Employees: 5,694.
- Industry: Pharmaceutical.
- Products: Includes citalopram, memantine, and other pharmaceuticals.
- Owned by: H. Lundbeck A/S.
- Subsidiaries: Lundbeck Australia, Lundbeck USA, and others.
- Parent organization: H. Lundbeck A/S.
- Stock exchange: Nasdaq Copenhagen A/S.
- Website: [www.lundbeck.com](http://www.lundbeck.com/).
- Sitelinks: 24 (as of source data).

## FAQs
**What is Lundbeck’s primary industry?**
Lundbeck is a pharmaceutical company specializing in the development, production, and marketing of drugs and pharmaceuticals.

**Where is Lundbeck headquartered?**
Lundbeck is headquartered in Valby, Copenhagen, Denmark.

**Who is the CEO of Lundbeck?**
The CEO of Lundbeck is Kåre Schultz.

**What products does Lundbeck produce?**
Lundbeck produces pharmaceuticals, including citalopram, memantine, and other licensed medications.

**How many employees does Lundbeck have?**
Lundbeck employs approximately 5,694 people.

**What is Lundbeck’s revenue?**
Lundbeck reported a revenue of €22 billion in 2023.

**Where is Lundbeck listed on the stock exchange?**
Lundbeck’s shares are listed on Nasdaq Copenhagen A/S.

**What is the parent organization of Lundbeck?**
Lundbeck is a subsidiary of H. Lundbeck A/S.

## Why It Matters
Lundbeck plays a significant role in the global pharmaceutical industry by developing and marketing essential medications, including citalopram (a widely prescribed antidepressant) and memantine (used in Alzheimer’s disease treatment). As a publicly traded company, it contributes to capital markets by offering shares to investors, facilitating economic growth and innovation. Lundbeck’s operations are deeply integrated into Denmark’s economy, supporting jobs and research in the pharmaceutical sector. Its commitment to sustainability and regulatory compliance further underscores its importance in the healthcare landscape.

## Notable For
- Being a pioneer in the development of citalopram, a widely used antidepressant.
- Producing memantine, a key medication for Alzheimer’s disease treatment.
- Operating as a publicly traded company on Nasdaq Copenhagen A/S.
- Maintaining a strong presence in the Danish pharmaceutical industry.
- Contributing to global healthcare through innovative drug development.

## Body

### Overview
Lundbeck is a Danish pharmaceutical company founded in 1915, specializing in the research, development, and marketing of pharmaceuticals. It is headquartered in Valby, Copenhagen, and is a publicly traded company with shares listed on Nasdaq Copenhagen A/S. The company is known for its contributions to the pharmaceutical industry, including the development of citalopram and memantine.

### History
Lundbeck was established in 1915 and has since grown into a significant player in the pharmaceutical sector. It has a long history of innovation, particularly in the development of medications that address mental health and neurodegenerative diseases.

### Products
Lundbeck produces a range of pharmaceuticals, including:
- **Citalopram**: A widely prescribed antidepressant.
- **Memantine**: A medication used in the treatment of Alzheimer’s disease.
- Other licensed pharmaceuticals.

### Operations
Lundbeck operates globally, with subsidiaries in various countries, including Australia and the United States. The company is committed to regulatory compliance and sustainability in its operations.

### Financials
- **Revenue**: €22 billion (2023).
- **Employees**: 5,694.
- **Stock Exchange**: Nasdaq Copenhagen A/S.

### Leadership
- **CEO**: Kåre Schultz.
- **Parent Organization**: H. Lundbeck A/S.

### Industry and Classification
Lundbeck is classified as a pharmaceutical company and operates within the broader pharmaceutical industry. It is a member of the Nasdaq Copenhagen stock exchange and is part of the Danish business landscape.

### Related Entities
- **Headquarters**: Valby, Copenhagen, Denmark.
- **Country of Operation**: Denmark.
- **Stock Exchange**: Nasdaq Copenhagen A/S.
- **Subsidiaries**: Lundbeck Australia, Lundbeck USA, and others.
- **Parent Organization**: H. Lundbeck A/S.

### Digital Presence
- **Website**: [www.lundbeck.com](http://www.lundbeck.com/).
- **Sitelinks**: 24 (as of source data).

### Impact
Lundbeck’s contributions to healthcare, particularly through the development of citalopram and memantine, have had a significant impact on global health outcomes. Its operations support jobs and innovation in the pharmaceutical sector, reinforcing its role as a key player in the industry.

## References

1. [Source](https://www.lobbyfacts.eu/datacard/h-lundbeck-a-s?rid=118500617129-29)
2. [Source](https://datacvr.virk.dk/enhed/virksomhed/56759913)
3. Danish Central Business Register
4. GRID Release 2017-01-10
5. [Source](https://info.ur.gov.lv/#/legal-entity/40003296636)
6. [Source](https://www.fsa-pharma.de/de/der-fsa/mitgliedschaft/unsere-mitglieder/)
7. Freebase Data Dumps. 2013
8. [Source](http://www.dr.dk/nyheder/penge/topchef-kaare-schultz-forlader-lundbeck-efter-aar-paa-posten)
9. [Danish Central Business Register](https://datacvr.virk.dk/data/visenhed?enhedstype=person&id=4003902167)
10. [Source](http://openleis.com/legal_entities/5493006R4KC2OI5D3470)
11. [Source](https://search.gleif.org/#/record/5493006R4KC2OI5D3470)
12. [Source](http://km.aifb.kit.edu/services/crunchbase/)
13. GRID Release 2015-12-14
14. GRID Release 2016-12-06
15. [Source](https://datacvr.virk.dk/data/visenhed?enhedstype=person&id=4000730560)
16. Quora
17. Aligned ISNI and Ringgold identifiers for institutions
18. [OpenAlex](https://docs.openalex.org/download-snapshot/snapshot-data-format)
19. Wikirate